Finding a source of primitive stem cells.
There are news reports about the positive impact that research on cord blood stem cells is having on the possible cure for numerous life threatening diseases. But with so many varying reports about it or even factions it is impossible to keep track of all its useful facts. Stem cells show a great level of plasticity which means they can generate and regenerate into many different types of cells and even organs within in our body. Potentially, if they can be removed from the donor and transfused into the patient then in the future, stem cells could be used to cure virtually any illness.
Stem cells are more frequently found in babies or even in embryos although it has been discovered that adult stem cells do exist. To date these have mostly been found in the brain but are dispersed freely amongst millions of other cells making the extraction incredibly difficult.
Cord blood stem cells, on the other hand, are very easy to remove. Because the process is completed after the child has been born and the umbilical cord cut and clamped there is no effect whatsoever on the baby, the parent or the birth itself.
How stem cells become T cells.
T cells are the cells that are responsible for fighting infection in children and are created when stem cells pass through the thymus gland. If the patient does not have an adequate number of effective stem cells in their blood then they will not be able to create the T cells. And subsequently they are much more likely to suffer serious infections. This, in turn, means that cord blood stem cells can be used to recreate T cells as well as other vital cells within the body of your child. The stem cells will then create an army of T cells to fight off infection and leave the body to function in a normal manner. As with a blood transfusion it is imperative to the operation’s success that the stem cells transfused are of the same type as the patient’s own blood. Using cord blood stem cells belonging to the patient themselves all but guarantees that this will be the case.
Stem cell testing.
The umbilical cord stem cell matrix is called Wharton’s jelly and is rich in primitive stem cells. These cells are one that has yet to progress, transform or produce other cells. Primitive stem cells are the most effective type of stem cells that can be used in a transfusion on any patient.
Typically a lot of testing has been done on animals to prove the viability of using stem cells taken from cord blood of newborn babies and amongst the most prominent of these tests, according to the online journal “stem cells”, have been tests carried out on pigs. In a human blood cord, similar to a pig umbilical cord, two arteries & vein are found and tests have shown positive results concerned with the storage and potency of the blood. The journal “stem cells” contains a lot of data relating to stem cells and articles on various related topics.
At present leukemia and anemia are the two most common diseases treated with stem cell transfusions although since stem cell research has grown in volume and results diseases such as Parkinson’s, Multiple Sclerosis and many different forms of cancer are also showing positive results.
A start-up company named Vitals Pro announced the launch of their wearable cardiac health monitoring device which is available as smart-watch and wristband. This device is specially made with many unique features, and enables users to easily monitor their cardiac health in modern lifestyle. The company has said that it is the first device, which can provide real-time medical grade heart health insights and it could save millions of lives every year from stroke, heart attack, and cardiac arrest. Also, it’s the first portable and user-friendly medical device that can give real-time alerts before a cardiac arrest and stroke will occur, it will also notify family Doctor of client situation anytime-anywhere.
VITALS PRO remains passionate regarding helping cardiac patients and people across the world to enhance their cardiac health and then prevent critical cardiovascular diseases through early detection, positive recommendations, and clinical grade monitoring.
The company is now inviting medical professionals, cardiologists, and heart patients to visit their official website to learn more, pre-order and review the quality and accuracy of Vitals Pro’s clinical grade bio-sensing features around the world. The product is available for pre-order on their website and should be shipping to medical professionals by May 2017.